The Lynx Group

Sabeeha Muneer, PhD


Authored Items

Utilizing Pharmacogenomics When Selecting Personalized Medicine for Patients with Chronic Pain

Faculty Perspectives in Chronic Pain, Part 5 A of 5 - Utilizing Pharmacogenomics for Patients with Chronic Pain

Pharmacotherapy, which remains the cornerstone of chronic pain management, includes analgesics such as nonsteroidal anti-inflammatory drugs (NSAIDs), the more potent opioids, and adjunct therapies such as antidepressants and anticonvulsants.1 It is well-recognized that interindividual differences exist in the general population in terms of pain perception, response to analgesic treatment, and [ Read More ]

Epidemiologic Assessments of Abuse-Deterrent Formulations

Faculty Perspectives in Chronic Pain, Part 4 of 5 - Uncategorized

Prescription opioid abuse is a significant public health concern in the United States, particularly abuse of controlled-release formulations that contain higher opioid content.1 The enormous abuse potential of prescription opioids is now well-recognized, and strategies to mitigate these risks are being implemented.1,2 This article provides an overview of the government’s [ Read More ]

Advocacy, Collaboration, and Education: Solutions to Public Health Issues in Chronic Pain

Faculty Perspectives in Chronic Pain, Part 2 of 5 - Uncategorized

Chronic pain affects approximately 100 million US adults, and has devastating consequences on quality of life (QoL) and functional status.1 Unfortunately, despite the availability of various pharmacologic and nonpharmacologic therapies, many patients with chronic noncancer pain continue to experience moderate or severe symptoms.1 Numerous barriers exist to the optimal management [ Read More ]

Sign me up!